These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 26337768)

  • 1. Interview with the Theme Issue Editors of Antibody-Drug Conjugates.
    Kulkarni A; Gukasyan H
    Pharm Res; 2015 Nov; 32(11):3453-7. PubMed ID: 26337768
    [No Abstract]   [Full Text] [Related]  

  • 2. Antibody-Drug Conjugates.
    Kulkarni AA; Gukasyan HJ
    Pharm Res; 2015 Nov; 32(11):3451-2. PubMed ID: 26275530
    [No Abstract]   [Full Text] [Related]  

  • 3. Internalization, Trafficking, Intracellular Processing and Actions of Antibody-Drug Conjugates.
    Xu S
    Pharm Res; 2015 Nov; 32(11):3577-83. PubMed ID: 26108878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Using the Lessons Learned From the Clinic to Improve the Preclinical Development of Antibody Drug Conjugates.
    Jackson D; Stover D
    Pharm Res; 2015 Nov; 32(11):3458-69. PubMed ID: 25339341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methods to Make Homogenous Antibody Drug Conjugates.
    Kline T; Steiner AR; Penta K; Sato AK; Hallam TJ; Yin G
    Pharm Res; 2015 Nov; 32(11):3480-93. PubMed ID: 25511917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive survey of chemical libraries for drug discovery and chemical biology: 2007.
    Dolle RE; Le Bourdonnec B; Goodman AJ; Morales GA; Thomas CJ; Zhang W
    J Comb Chem; 2008; 10(6):753-802. PubMed ID: 18991466
    [No Abstract]   [Full Text] [Related]  

  • 7. Antibody-Drug Conjugates and Small Molecule-Drug Conjugates: Opportunities and Challenges for the Development of Selective Anticancer Cytotoxic Agents.
    Casi G; Neri D
    J Med Chem; 2015 Nov; 58(22):8751-61. PubMed ID: 26079148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor Targeting with Small Molecule-Drug Conjugates (SMDCs) - Can They be Better than ADCs?
    Altmann KH
    Chimia (Aarau); 2018 Mar; 72(3):154-155. PubMed ID: 29631670
    [No Abstract]   [Full Text] [Related]  

  • 9. Hacking into the granuloma: could antibody antibiotic conjugates be developed for TB?
    Ekins S
    Tuberculosis (Edinb); 2014 Dec; 94(6):715-6. PubMed ID: 25287628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preclinical Pharmacokinetic Considerations for the Development of Antibody Drug Conjugates.
    Kamath AV; Iyer S
    Pharm Res; 2015 Nov; 32(11):3470-9. PubMed ID: 25446773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fragments and hot spots in drug discovery.
    Vajda S; Whitty A; Kozakov D
    Oncotarget; 2015 Aug; 6(22):18740-1. PubMed ID: 26300051
    [No Abstract]   [Full Text] [Related]  

  • 12. Alphav integrin-targeted immunoconjugates regress established human tumors in xenograft models.
    Chen Q; Millar HJ; McCabe FL; Manning CD; Steeves R; Lai K; Kellogg B; Lutz RJ; Trikha M; Nakada MT; Anderson GM
    Clin Cancer Res; 2007 Jun; 13(12):3689-95. PubMed ID: 17575234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Understanding Protein-Protein Interactions: Essential Players in (Patho)physiology (Part 2).
    Wilson AJ; Gunning PT
    ChemMedChem; 2016 Apr; 11(8):732-3. PubMed ID: 27061459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody-drug conjugates in tumor therapy.
    Sammet B; Steinkühler C; Sewald N
    Pharm Pat Anal; 2012 Mar; 1(1):65-73. PubMed ID: 24236714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The application of small molecule bioactive probes in the identification of cellular targets].
    Zhang J; Zhou HC
    Yao Xue Xue Bao; 2012 Mar; 47(3):299-306. PubMed ID: 22645752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel approaches to map small molecule-target interactions.
    Kapoor S; Waldmann H; Ziegler S
    Bioorg Med Chem; 2016 Aug; 24(15):3232-45. PubMed ID: 27240466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Small molecules and their role in effective preclinical target validation.
    Clegg MA; Tomkinson NC; Prinjha RK; Humphreys PG
    Future Med Chem; 2017 Sep; 9(14):1579-1582. PubMed ID: 28828889
    [No Abstract]   [Full Text] [Related]  

  • 18. Extracellular Antibody Drug Conjugates Exploiting the Proximity of Two Proteins.
    Marshall DJ; Harried SS; Murphy JL; Hall CA; Shekhani MS; Pain C; Lyons CA; Chillemi A; Malavasi F; Pearce HL; Thorson JS; Prudent JR
    Mol Ther; 2016 Oct; 24(10):1760-1770. PubMed ID: 27434591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High throughput testing of drug library substances and monoclonal antibodies for capacity to reduce formation of cystatin C dimers to identify candidates for treatment of hereditary cystatin C amyloid angiopathy.
    Östner G; Lindström V; Postnikov AB; Solovyeva TI; Emilsson ÖI; Grubb A
    Scand J Clin Lab Invest; 2011 Dec; 71(8):676-82. PubMed ID: 22017167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-guided Discovery of Dual-recognition Chemibodies.
    Cheng AC; Doherty EM; Johnstone S; DiMauro EF; Dao J; Luthra A; Ye J; Tang J; Nixey T; Min X; Tagari P; Miranda LP; Wang Z
    Sci Rep; 2018 May; 8(1):7570. PubMed ID: 29765112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.